Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+16.98%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$75.2B
AUM Growth
+$9.1B
Cap. Flow
+$1.93B
Cap. Flow %
2.57%
Top 10 Hldgs %
12.06%
Holding
4,018
New
612
Increased
1,577
Reduced
1,314
Closed
496

Sector Composition

1 Technology 19.67%
2 Healthcare 15.79%
3 Consumer Discretionary 12.38%
4 Financials 11.51%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MSGM icon
3326
Motorsport Games
MSGM
$14M
$84.7K ﹤0.01%
+29,200
EDTK icon
3327
Skillful Craftsman
EDTK
$16.7M
$83.7K ﹤0.01%
96,700
-13,900
RBOT icon
3328
Vicarious Surgical
RBOT
$38.2M
$83.5K ﹤0.01%
11,134
-1,500
KALA icon
3329
KALA BIO
KALA
$10M
$82.8K ﹤0.01%
+17,400
CVRX icon
3330
CVRx
CVRX
$233M
$82.3K ﹤0.01%
+14,000
GRCE
3331
Grace Therapeutics
GRCE
$41.3M
$82K ﹤0.01%
27,625
-14,556
VTGN icon
3332
VistaGen Therapeutics
VTGN
$124M
$81K ﹤0.01%
40,500
+15,700
YQ
3333
17 Education & Technology Group
YQ
$35.7M
$80.7K ﹤0.01%
36,830
+15,600
COYA icon
3334
Coya Therapeutics
COYA
$102M
$80.5K ﹤0.01%
14,000
+1,800
IMDX
3335
Insight Molecular Diagnostics
IMDX
$111M
$78.8K ﹤0.01%
+26,100
SBFM
3336
Sunshine Biopharma
SBFM
$7.06M
$77.9K ﹤0.01%
+54,093
CLRO icon
3337
ClearOne
CLRO
$10.3M
$77.3K ﹤0.01%
13,447
-1,081
SOHO
3338
Sotherly Hotels
SOHO
$16.2M
$76.7K ﹤0.01%
80,714
+200
ANRO icon
3339
Alto Neuroscience
ANRO
$153M
$76.3K ﹤0.01%
+34,700
UONE icon
3340
Urban One Class A
UONE
$59.9M
$75.5K ﹤0.01%
47,200
+100
PCLA
3341
PicoCELA Inc
PCLA
$14.7M
$74K ﹤0.01%
+45,700
ARMP icon
3342
Armata Pharmaceuticals
ARMP
$115M
$73.9K ﹤0.01%
38,896
+300
ELUT icon
3343
Elutia
ELUT
$37.7M
$73.3K ﹤0.01%
37,016
-700
WRAP icon
3344
Wrap Technologies
WRAP
$128M
$73K ﹤0.01%
+46,800
ATHA icon
3345
Athira Pharma
ATHA
$15M
$72.8K ﹤0.01%
241,000
+22,000
PSHG icon
3346
Performance Shipping
PSHG
$22.9M
$72.8K ﹤0.01%
41,584
+13,184
SOGP
3347
Sound Group
SOGP
$48.4M
$72K ﹤0.01%
15,158
INCR
3348
Intercure
INCR
$87.2M
$71.9K ﹤0.01%
48,900
+500
AAME icon
3349
Atlantic American Corp
AAME
$58.7M
$71.1K ﹤0.01%
33,400
+300
GROV icon
3350
Grove Collaborative
GROV
$61.9M
$70.8K ﹤0.01%
61,600
+5,200